Jennifer Sherak
SVP & President, Specialty Physician Services
Jennifer Sherak (Jenny) serves as SVP & President, Specialty Physician Services. In this role, she is responsible for leading AmerisourceBergen’s physician practice distribution and solutions businesses, specifically Besse Medical, Oncology Supply, ION Solutions, IPN Solutions, and IntrinsiQ Specialty Solutions.
Jenny’s focus is to drive the strategic direction for our physician practice portfolio of services, develop and execute on a comprehensive strategy for innovation, and optimize the value we deliver to our customer base.
Previously, Jenny served as the Global Head of Oncology Pipeline Commercialization and Business Development at Takeda Pharmaceuticals. In this role, she was responsible for defining long and short-term growth strategies for the oncology business unit and ensuring continued business unit growth through maximizing the innovative global pipeline and leveraging external collaborations and mergers and acquisitions.
Prior to joining Takeda, Jenny was the Global Commercial Strategy Lead for Hematology at Shire Pharmaceuticals where she led integration efforts from the acquisition of Baxalta and greatly expanded the global availability of leukemia medicines for patients around the world.
During Jenny’s comprehensive career in the pharmaceutical industry, she has held strategic commercial positions with Baxalta, Biodesix, Celgene, Bristol Myers Squibb and Novartis leading US and global commercial strategy teams and managing product lifecycle planning.
Jenny received her undergraduate degree from East Carolina University with a Bachelor of Science in chemistry and graduated from The College of William and Mary with a Master of Business Administration.
Previously, Jenny served as the Global Head of Oncology Pipeline Commercialization and Business Development at Takeda Pharmaceuticals. In this role, she was responsible for defining long and short-term growth strategies for the oncology business unit and ensuring continued business unit growth through maximizing the innovative global pipeline and leveraging external collaborations and mergers and acquisitions.
Prior to joining Takeda, Jenny was the Global Commercial Strategy Lead for Hematology at Shire Pharmaceuticals where she led integration efforts from the acquisition of Baxalta and greatly expanded the global availability of leukemia medicines for patients around the world.
During Jenny’s comprehensive career in the pharmaceutical industry, she has held strategic commercial positions with Baxalta, Biodesix, Celgene, Bristol Myers Squibb and Novartis leading US and global commercial strategy teams and managing product lifecycle planning.
Jenny received her undergraduate degree from East Carolina University with a Bachelor of Science in chemistry and graduated from The College of William and Mary with a Master of Business Administration.